We at Magellan Biologics & Consulting are proud of this great achievement for our sister Company ExcellGene SA and congratulate, together with the whole ExcellGene team, all the consortium members: Bharat Biotech International Limited and the University of Sydney on their commitment to the progress of science and medicine! This new milestone for CEPI (Coalition for Epidemic Preparedness Innovations) is of paramount importance in our global effort towards the objective of a long-term control of the #sarscov2 virus.
A Historic Milestone: Magellan Biologics & Consulting Enters a New Era with ARCHIMED
Magellan Biologics and its sister company ExcellGene have entered a new strategic partnership with ARCHIMED, a global med-tech investment firm Press Release ARCHIMED acquires cell
25 September 2025
